Axiom Investors LLC Supernus Pharmaceuticals, Inc. Transaction History

Axiom Investors LLC

$11.2 Billion
Q3 2024

A detailed history of Axiom Investors LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Axiom Investors LLC holds 50,335 shares of SUPN stock, worth $1.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

50,335

Previous 54,860 8.25%

Holding current value

$1.79 Million

Previous $1.47 Million 6.95%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$25.77 - $35.16 $116,609 - $159,098	-4,525 Reduced 8.25%	50,335 $1.57 Million
Q2 2024 Aug 13, 2024	BUY	$25.99 - $33.85 $16,243 - $21,156	625 Added 1.15%	54,860 $1.47 Million
Q1 2024 May 13, 2024	BUY	$27.11 - $35.17 $156,695 - $203,282	5,780 Added 11.93%	54,235 $1.85 Million
Q4 2023 Feb 12, 2024	BUY	$22.72 - $29.68 $791,564 - $1.03 Million	34,840 Added 255.89%	48,455 $1.4 Million
Q3 2023 Nov 13, 2023	SELL	$27.57 - $32.91 $283,557 - $338,479	-10,285 Reduced 43.03%	13,615 $375,000
Q2 2023 Aug 10, 2023	SELL	$29.91 - $38.73 $50,697 - $65,647	-1,695 Reduced 6.62%	23,900 $718,000
Q1 2023 May 12, 2023	BUY	$34.93 - $42.03 $187,050 - $225,070	5,355 Added 26.46%	25,595 $927,000
Q4 2022 Feb 09, 2023	BUY	$31.09 - $37.88 $629,261 - $766,691	20,240 New	20,240 $721,000
Q3 2018 Nov 13, 2018	SELL	$42.7 - $56.55 $2.44 Million - $3.24 Million	-57,230 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$44.1 - $59.85 $245,637 - $333,364	5,570 Added 10.78%	57,230 $3.43 Million
Q1 2018 May 14, 2018	SELL	$37.15 - $46.9 $186,864 - $235,907	-5,030 Reduced 8.87%	51,660 $2.37 Million
Q4 2017 Feb 14, 2018	SELL	$36.4 - $42.6 $1.54 Million - $1.8 Million	-42,186 Reduced 42.67%	56,690 $2.26 Million
Q3 2017 Nov 09, 2017	SELL	$36.75 - $49.65 $2.68 Million - $3.62 Million	-72,955 Reduced 42.46%	98,876 $3.96 Million
Q2 2017 Aug 14, 2017	BUY	N/A	171,831	171,831 $7.41 Million

Others Institutions Holding SUPN

# of Institutions

281

Shares Held

60.6M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.

Account

Axiom Investors LLC Supernus Pharmaceuticals, Inc. Transaction History